Replies to post #3211 on InMed Pharmaceuticals Inc (INM)

[IAmTopG]

They do not deal with THC itself as far as I understand. So in theory the regulations itself probably does not affect the SP that much (in theory)

This is a life science company that develops drug products for medical benefit. Having said that, I am curious if anyone out there are holding purchases as we all know potential dilution associated with clinical trials. Already holding 17,300 shares...Just wondering if I should wait..

[wallstreetbuyer]

My understanding is that you can consider INMED as a biotech company and its potential pipeline is Cannabiniods. For biotech cash is key issue. What is the current cash situation?

[lesgetrich]

Recreational use going legal in Canada will make it easier and probably more mainstream to do research on marijuana and cannabis. InMed's biosynthesis allows them to mass produce cannabinoids, including CBD and THC, without the expense of growing plants. So to answer your question, any recreational product that uses extracted THC or CBD could, theoretically, substitute a much cheaper biosynthesized product using InMed's technique. It will be interesting to see if/when they license it for recreational production .